Mass tort settlement news moved fast during the week of July 13, 2026. A federal appeals court revived hundreds of Tylenol autism claims. Pfizer edged toward a Depo-Provera resolution. Meanwhile, a J&J talc trial ended in another mistrial. New York also sued major chemical makers over hidden PFAS risks. This week’s mass tort settlement news touches nearly every major litigation category. Below, we break down the developments by type. For background, see our guide on what a mass tort is and how these cases work.
Pharmaceutical Mass Tort Settlement News This Week
The biggest pharmaceutical story came from Manhattan. The 2nd U.S. Circuit Court of Appeals revived more than 500 Tylenol autism lawsuits. These cases sit in the acetaminophen MDL (MDL 3043) before Judge Denise Cote. The court ruled that expert testimony was wrongly excluded. As a result, parents alleging prenatal Tylenol use caused autism and ADHD may proceed. However, the panel stressed it did not decide whether Tylenol causes autism. Maker Kenvue now faces renewed exposure. Affected families should still consult a licensed attorney before acting.
In addition, Depo-Provera litigation reached a turning point. Pfizer reached a global settlement framework in June 2026. The Depo-Provera MDL (MDL 3140) now holds more than 5,800 cases in the Northern District of Florida. Plaintiffs allege the contraceptive raised meningioma brain tumor risk. A new study this week added further evidence of that link. The first bellwether trial is scheduled for December 7, 2026. This mass tort settlement news signals momentum toward resolution.
Opioid litigation stayed active too. Settlement funds are now flowing to rural Kentucky and Colorado treatment programs. Meanwhile, a Washington state trial began against Albertsons. Regulators accuse the pharmacy chain of overworking pharmacists and fueling the opioid crisis. Separately, a $200 million generic drug antitrust settlement opened claims for eligible consumers. Track ongoing pharmaceutical filings on our active MDL cases hub. You can also review the Ozempic lawsuit page for the latest GLP-1 developments.
Medical Device Lawsuit Developments
A striking medical device claim surfaced this week. A new lawsuit alleges Boston Scientific sales reps made unauthorized spinal cord stimulator adjustments. The complaint says reps altered device settings without proper physician oversight. For example, patients reportedly received changes from non-clinical staff. This raises serious patient safety questions. As a result, plaintiffs’ lawyers are watching for a possible litigation wave. Anyone with a stimulator injury should document their device history carefully.
Meanwhile, established device cases kept moving. The Bard hernia mesh MDL (MDL 2846) still holds roughly 24,000 active cases in Ohio. A tiered, points-based settlement framework continues processing claims. For details, see our hernia mesh lawsuit guide. In addition, the 3M Combat Arms earplug settlement remains in its payout phase. That program has distributed more than $3.1 billion to claimants. This device-focused mass tort settlement news shows how long payout timelines can run. Every recovery depends on individual case facts, not guarantees.
Environmental Contamination Case Updates
Environmental litigation dominated headlines this week. New York sued 3M, DuPont, and others over PFAS risks allegedly hidden for decades. The suit targets so-called “forever chemicals” in water and soil. Meanwhile, the AFFF firefighting foam MDL (MDL 2873) still holds more than 15,200 personal injury cases. Prior water-system deals were massive. 3M agreed to pay up to $10.3 billion. DuPont, Chemours, and Corteva added $1.185 billion. Read more on our AFFF lawsuit page.
However, personal injury AFFF claims remain unresolved. These cases cover cancers linked to PFAS exposure. Individual recovery is still uncertain, so affected people may qualify but should verify eligibility. In addition, the Camp Lejeune water contamination program keeps processing claims under the federal Justice Act. See our Camp Lejeune lawsuit hub for filing status. Meanwhile, a Lancashire chemicals factory facing legal claims announced closure this week. This mass tort settlement news underscores growing corporate exposure over contamination.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Herbicide cases sent mixed signals. Pesticide makers stacked courtroom wins against environmental and public health groups. However, Roundup and Paraquat personal injury cases continue. More than 6,400 Paraquat claims remain stayed as talks progress. Compare state rules on our tort reform by state page and the Roundup lawsuit guide.
Consumer Product Litigation News
Consumer product litigation produced another dramatic result. A J&J talcum powder trial ended in a mistrial after a deadlocked jury. This adds to a long history of hung juries in talc cases. The talc MDL (MDL 2738) now exceeds 68,000 pending actions. Meanwhile, social media addiction litigation advanced. In the MDL (MDL 3047), TikTok and Snap settled before a key trial. A jury also hit Meta and Google with a $6 million verdict earlier this year.
In addition, California school districts and LAUSD filed suits seeking money and platform changes. Separately, Uber faces an investor lawsuit tied to driver sexual assault claims. The Uber MDL (MDL 3084) surged past 3,900 cases after early bellwether verdicts. For hair-related claims, review our hair relaxer lawsuit guide. This mass tort settlement news reminds readers that consumer cases move unevenly. Verdicts vary widely, so consult a licensed attorney about your specific situation. You can also read how mass tort settlements work.
Key Deadlines and What to Watch in Mass Tort Settlement News
Several dates deserve attention. The table below tracks upcoming milestones from this week’s mass tort settlement news.
| Litigation | MDL | Next Milestone |
|---|---|---|
| Depo-Provera | MDL 3140 | Bellwether trial Dec. 7, 2026 |
| Tylenol autism | MDL 3043 | Remanded to Judge Cote for further proceedings |
| NEC baby formula | MDL 3026 | Next bellwether expected August 2026 |
| Albertsons opioids | WA state trial | Trial underway now |
| AFFF firefighting foam | MDL 2873 | Personal injury bellwether pending |
Meanwhile, watch the Tylenol remand closely. Judge Cote must now reconsider causation evidence. As a result, that ruling could reshape the whole litigation. In addition, Pfizer’s Depo-Provera settlement terms remain unannounced. For example, payout tiers and amounts are still being finalized. Nothing here promises any outcome, and every potential recovery depends on individual facts. Unsure where you stand? Take our eligibility quiz. Then review the full settlement news archive. Always consult a licensed attorney before filing any claim.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed July 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- New Jersey Tort Reform Guide
- Texas Tort Reform Guide
- North Carolina Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.